BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia

H, Ariffin (2011) BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Experimental Hematology, 39 (3). pp. 321-9.

[img] PDF
File0006.PDF

Download (301kB)

Abstract

-

Item Type: Article
Uncontrolled Keywords: BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic l
Subjects: R Medicine
Depositing User: MR. ADNAN YAHYA
Date Deposited: 10 Mar 2011
Last Modified: 27 Feb 2012
URI: http://repository.um.edu.my/id/eprint/10233

Actions (login required)

View Item View Item